BALTIMORE, April 12, 2023 /PRNewswire/ — Latham BioPharm Group (LBG), part of Sia Partners , is excited to announce the addition of a new capability centered around Digital Health Consulting. Digital transformation is evolving and revolutionizing the way healthcare is delivered globally. The increases in wearable medical devices and over-the-counter healthcare products, along with the widespread adoption of telemedicine, has decentralized healthcare, enabled patients to take control of their own health, and facilitated the delivery of high-quality healthcare in the home and in resource-limited settings. In addition, the expanded use of Artificial Intelligence (AI) and data analysis has improved the quality of healthcare delivery by facilitating early disease detection, allowing for more data-driven treatment decisions and enabling precise robotic surgeries. Digital tools, such as new AI engines, the expanding functionalities of smart devices, and the sophistication of virtual reality, will continue to accelerate healthcare transformation. These same drivers are also impacting the way clinical trials are executed and have facilitated a new paradigm around the decentralization of clinical trials. LBG is now well positioned to support this transformation. Continue Reading Sia Partners Latham BioPharm Group, Inc. LBG has a long history of supporting healthcare product development from initial product […]
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
